Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?

por Thotamgari, Sahith Reddy, Grewal, Udhayvir Singh, Sheth, Aakash R., Babbili, Akhilesh, Dominic, Paari
Publicado 2022

Impact of Atrial Fibrillation on Outcomes in Patients Hospitalized With Nontraumatic Intracerebral Hemorrhage

por Thotamgari, Sahith Reddy, Babbili, Akhilesh, Bucchanolla, Prabandh, Thakkar, Samarthkumar, Patel, Harsh P., Spaseski, Maja B., Graff-Radford, Jonathan, Rabinstein, Alejandro A., Asad, Zain Ul Abideen, Asirvatham, Samuel J., Holmes, David R., Deshmukh, Abhishek, DeSimone, Christopher V.
Publicado 2023